MDT Q4 2025 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.9B+3.9% YoY

Gross Profit

$5.8B64.7% margin

Operating Income

$1.4B16.1% margin

Net Income

$1.1B11.8% margin

EPS (Diluted)

$0.82

QoQ Revenue Growth

+7.7%

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$2.1B

Stock-Based Comp.

$89M

Balance Sheet

Total Assets

$91.7B

Total Liabilities

$43.4B

Stockholders' Equity

$48.0B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.9B	$8.6B	+3.9%
Gross Profit	$5.8B	$5.5B	+4.2%
Operating Income	$1.4B	$1.1B	+36.4%
Net Income	$1.1B	$654M	+61.6%

Revenue Segments

Cardiac and Vascular Group

$3.3B37%

Neuroscience Group

$2.6B29%

Medical Surgical

$2.2B25%

Diabetes Group

$728M8%

Geographic Segments

UNITED STATES

$4.5B51%

Total Other Countries, Excluding United States and Ireland

$4.3B49%

IRELAND

$29M0%